Corvia Medical said it launched a heart failure device trial that will include the collection and analysis of data with PhysIQ’s continuous remote monitoring platform. The Phase III trial is designed to evaluate the efficacy of Tewksbury, Mass.-based Corvia’s interatrial shunt in patients with heart failure. The randomized, controlled, double-blinded study includes plans to provide […]
BioSig inks deal with Mayo Clinic
BioSig Technologies (NSDQ:BSGM) said yesterday that it signed a new licensing agreement with Mayo Clinic to further its Pure EP system, less than two months after the Mayo Clinic invested $1 million in BioSig’s first product. Westport, Conn.-based BioSig and the Rochester, Minn.-based clinic inked a 10-year strategic partnership agreement for the Pure EP system’s […]
V-Wave’s interatrial shunt lands another breakthrough nod from FDA
V-Wave said yesterday that it won FDA breakthrough device designation for its interatrial shunt for pulmonary arterial hypertension, marking the second time in less than a month that the company has earned a breakthrough nod. The PAH shunt is designed to be placed in the heart through a catheter inserted via a vein in the […]
FDA clears HeartFlow Planner
HeartFlow said yesterday that it won FDA clearance for its Planner tool for coronary artery disease intervention. The Redwood City, Calif.-based company developed FFRct, which works by taking the data from a standard CT scan and applying algorithms that result in a color-coded 3D “map” detailing changes in flow across coronary lesions. The Planner virtual […]
CroíValve adds $4.4m to initiate clinical trials
CroíValve said today that it secured more than $4 million in additional financing as it develops a treatment for tricuspid regurgitation. The funding, which amounts to more than $4.4 million (€4 million) includes more than $2.7 million (€2.5 million) from the European Union under its Horizon 2020 SME Instrument grant. The remaining $1.7 million (€1.5 […]
Cardiac Dimensions touts Carillon TMVR study
Cardiac Dimensions today touted a clinical study of its Carillon mitral contour system in treating the primary cause of functional mitral regurgitation (FRM) in patients with heart failure. Carillon is a right heart transcatheter mitral valve repair (TMVR) device designed to treat FRM in patients with mitral regurgitation grades of 2+, 3+ and 4+ in […]
Apple announces medical studies using new Research app
Apple (NSDQ:AAPL) said yesterday that it is launching medical studies into women’s health, hearing, and heart function and movement with its new Research app. The Cupertino, Calif.-based company said the app will show how medical research is conducted and allow participants to contribute to potential medical discoveries. The Research app will be available as a free […]
Dance Biopharm, DarioHealth partner up on smart inhaler
Dance Biopharm said today that it has partnered with DarioHealth (NSDQ:DRIO) to integrate Dance’s smart inhaler into DarioHealth’s digital therapeutics program. Durham, N.C.-based Dance Biopharm’s smart inhaler includes vibrating mesh designed to create a soft mist that improves medication coverage in the lung. In clinical trials, the device delivered insulin in mist form with a faster […]
Viant acquires Meraqi Medical
Viant announced today that it has acquired Meraqi Medical marking the medical device contract manufacturer’s fourth acquisition in two years. Viant said the acquisition of Fremont, Calif.-based Meraqi will expand its range of interventional technologies, bioelectronics and minimally invasive surgical devices. It will also offer a West Coast design and development hub to compliment Viant’s […]
PerkinElmer prices $850m offering
PerkinElmer (NYSE:PKI) yesterday priced a stock offering of $850 million. The offering consists of 3.3% senior notes due in 2029 at an issue price of 99.67% of the principal amount. PerkinElmer said it expects to complete the offering on Sept. 12, and that the notes will pay interest on a semi-annual basis. Waltham, Mass.-based PerkinElmer said […]
iRhythm closes $115m offering
iRhythm Technologies (NSDQ:IRTC) said yesterday that it closed its underwritten public offering of common stock for gross proceeds exceeding $100 million. The San Fransisco-based company said it offered nearly 1.6 million shares at $73 per share, including the exercise in full of the underwriters’ option to purchase an additional 205,479 shares. iRhythm initially estimated net proceeds […]
